Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 2;29(11):e42-e43.
doi: 10.1093/ibd/izad222.

Reply: "Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?"

Danny Glickman  1 , Shannon Dalessio  2 , Wesley M Raup-Konsavage  3 , Kent E Vrana  3 , Matthew D Coates  2   3
Affiliations
Editorial

Reply: "Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?"

Danny Glickman et al. Inflamm Bowel Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None declared.

Comment in

Comment on

References

    1. Glickman D, Dalessio S, Raup-Konsavage WM, Vrana KE, Coates MD.. The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study. Inflamm Bowel Dis. 2023;••:•••-•••. - PMC - PubMed
    1. Gubatan J, Staller K, Barshop K, Kuo B.. Cannabis abuse is increasing and associated with increased emergency department utilization in gastroenterology patients. Dig Dis Sci. 2016;61(7):1844-1852. - PubMed
    1. Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN.. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease. Inflamm Bowel Dis. 2014;20(3):472-480. - PubMed
    1. Dalavaye N, Erridge S, Nicholas M, et al. . The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. Expert Rev Gastroenterol Hepatol. 2023;17(1):85-98. - PubMed
    1. Doeve BH, van de Meeberg MM, van Schaik FDM, Fidder HH.. A systematic review with meta-analysis of the efficacy of Cannabis and Cannabinoids for inflammatory bowel disease: what can we learn from randomized and nonrandomized studies? J Clin Gastroenterol. 2021;55(9):798-809. - PubMed